chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the second dose of the vaccine, I experienced severe pain at the injection site and some swelling, a lot of muscle and joint pain overnight up until the next day.  In addition I experienced body chills.  After 2 hours of taking  Tylenol the symptoms faded and the pain at the injection site also disappeared.
This case was reported by a healthcare professional and described the occurrence of petechiae in a 5 year old subject of unspecified gender who was vaccinated Pediarix (GlaxoSmithKline) for prophylaxis. Concurrent vaccination included poliomyelitis vaccine inactivated given on the same date as suspect Infanrix. On an unspecified date, the subject received a dose of Infanrix in an unknown deltoid. At an unspecified time after vaccination with Infanrix, the subject experienced petechiae on the right cheek. The event resolved within one day without treatment.
Red painful swollen indurated area R arm at site of injection, low grade fever (99 F) began 2/5/2008, 1 day after administration, 2/4/2008; Keflex called in 2/5/08; OV 2/6/2008 prescribed Septra and changed Keflex to Augmentin; 2/7/2008 afebrile, reaction fading but spreading distally in response to gravity; 2/8/08 phone call patient lightheaded, headache, stomach pain; advised to change Augmentin back to Keflex and make OV. Did not show for follow up OV.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 31-OCT-2015, the patient accidentally received a dose of VARIVAX (Merck) (dose, route, therapy type, lot number unknown) instead of ZOSTAVAX. No adverse effects were reported. No product quality complaint was filled. Additional information has been accidentally.
Pt wanted a flu shot and we accidentally gave a covid shot. He already had 2 Moderna shots, the last on 4/10. We gave the flu shot after realizing mistake.
Patient received dose 1 of Moderna vaccine on 3/2/2021.  She returned for a second dose on 3/30/2021 and notified team she had a stroke 3 days after receiving the vaccine.     Vaccine not given today.   Patient admitted to another healthcare system for stroke.
Phoned the office today-requesting to be seen. Explains that she got sick on January 23-day after last visit here. Awoke that morning with a sore throat, sneezing, aching all over. Over the next couple of days felt feverish, had chills, actually checked her temperature on a couple of occasions which was "100.1".  Started taking some OTC cold and flu. Aching was so bad that 2 days ago spent the entire day in bed. Sore throat is not gone, aching is doing a whole lot better, but the reason she comes in today is because of nasal congestion, frontal headache and developing a cough and tightness in her chest over the past couple of days. I asked about the feverishness and chills, has not had any feverishness or chills over the past 24 hours. I asked about the earache, ears have been popping a bit but denies any earache per se. I asked about rhinorrhea has been blower her nose, sometimes gets out some yellow mucus, sometimes could even get out some blood. I asked about coughing, has been coughing, I asked about sputum production, states whatever she coughs up she swallows. Did receive the H1N1 shot the day before she got sick, doesn't know if this could be related or not. General appearance is that of an alert, oriented times three, female with an episodic dry cough, in no visible distress otherwise. Ear canals and tympanic membranes are clear. Nasal turbinates are a bit congested with a bit of adherent clear mucus. Posterior pharynx is clear. Chest is clear to P & A. Heart is regular S1, S2. URI. Advised patient I cannot say with certainty whether or not this may or may not be causally related to the H1N1 vaccine. All things considered will treat with Doxycycline 100 mg. Advised patient she could also continue current OTC measures. Rx: Doxycycline:100 mg:1:bid:20.0
1:30 AM - woke up with pounding migraine - took migraine medication at 1:30 and 6:00 AM. HA tolerable by 10:00 AM, noticed swelling of total face. Swelling gone by 11-2014 AM. Washed out the next day.
patient received dose of vaccine that was past beyond use date; manufacturer confirmed no need to revaccinate due to determination that vaccine was still active at time of administration
19 hours after my second dosage of vaccine, I had a period of intense nausea followed by fainting and lost consciousness for a matter of a few seconds. while regaining consciousness I experienced involuntary convulsions/spasms of my arms and legs. I have no history of fainting or seizures.
Body broke-out in hives/rash and insanely itchy. Been taking prednisone pills and steroid shot. Still itchy and breaking-out 6 days later.
In a lot of pain; Kidney area on right side started hurting really bad; Infection in right kidney; Had a swollen right kidney; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 06-Oct-2021 and was forwarded to Moderna on 06-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RENAL PAIN (Kidney area on right side started hurting really bad), KIDNEY INFECTION (Infection in right kidney), OEDEMATOUS KIDNEY (Had a swollen right kidney) and PAIN (In a lot of pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No medical history was reported by the reporter.     On 04-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Oct-2021, the patient experienced RENAL PAIN (Kidney area on right side started hurting really bad), KIDNEY INFECTION (Infection in right kidney) and OEDEMATOUS KIDNEY (Had a swollen right kidney). On 06-Oct-2021, the patient experienced PAIN (In a lot of pain). At the time of the report, RENAL PAIN (Kidney area on right side started hurting really bad), KIDNEY INFECTION (Infection in right kidney) and OEDEMATOUS KIDNEY (Had a swollen right kidney) outcome was unknown and PAIN (In a lot of pain) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The concomitant medications were not provided. The patient does not took any medications. The patient had no underlying health issues.  On 04-Oct-2021, the patient received first dose but after nine hours, the patient had swollen right kidney and an infection in right kidney. The patient had no health issues until vaccination. The kidney area on the right side also started hurting really bad.  On 05-Oct-2021, the patient went to urgent care and was currently off work. The patient did not plan to take second vaccine. The patient received a shot of an antibiotic Cefdinir in the urgent care.   On 06-Oct-2021, the patient was in lot in pain.
bruises around injection site and all around the left arm; bruises around injection site and all around the left arm; severe fatigue; This is a spontaneous report from a contactable consumer(patient). A 21-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: ER8733; Expiration Date: 31Jul2021), first dose via an unspecified route of administration, administered in left arm on 07Apr2021 as SINGLE DOSE for covid-19 immunization. Patient was 21 years old at the time of vaccination. Patient's medical history and concomitant medications were not reported. Patient did not receive any prior vaccinations within 4 weeks of first administration of vaccination. On 08Apr2021 patient experienced severe fatigue, stated it was really bad. On 11Apr2021 patient had bruises around injection site and all around the left arm, a lot of them. States the fatigue has improved some but he was just so exhausted. Wanted to also know is there any chance he is having low platelet counts. The outcome of the event bruises around injection site and all around the left arm was unknown and severe fatigue was reported as recovering.  No follow-up attempts are needed; No further information is expected.
Information has been received from a registered nurse concerning a 17 year old female who on 25-JAN-2009 was vaccinated with a first dose of GARDASIL 0.5 mL.  In February 2009 ("2 weeks later after getting the vaccine"), the patient experienced joint pain in ankle, legs and wrists.  The patient sought unspecified medical attention.  At the time of reporting, the patient's joint pain in ankle, legs and wrists persisted.  No further information is available.
BP 130/55, P 92bpm, T 101 degrees F, short of breath, coughing, pulsing ache from left side of stomach radiating to left inner thigh, 4"x3.5" elliptical shaped hot, red, swollen patch @ injection site. Head, muscle, bone ache. Incontinence.
When standing up to walk out of the vaccination room the patient passed out and was caught by the boyfriend who was with her. Paramedics were called. Patient mentioned at the second dose that they deemed it as a panic attack.
Coughing a lot; Runny nose; Rising blood pressure occurred after getting the vaccine; Headaches; Nausea; Can not walk because of fast heart beating.; Pains at arm and chest; Pains at arm and chest; Redness; Aweight on the chest; Can not walk because of fast heart beating; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest) and PALPITATIONS (Can not walk because of fast heart beating) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Contrast media allergy (A nurse thinks that patient is allergic to dye contrast).    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), GAIT DISTURBANCE (Can not walk because of fast heart beating.) and NAUSEA (Nausea). On an unknown date, the patient experienced COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine) and HEADACHE (Headaches). At the time of the report, PAIN IN EXTREMITY (Pains at arm and chest), CHEST PAIN (Pains at arm and chest), ERYTHEMA (Redness), CHEST DISCOMFORT (Aweight on the chest), PALPITATIONS (Can not walk because of fast heart beating), COUGH (Coughing a lot), RHINORRHOEA (Runny nose), HYPERTENSION (Rising blood pressure occurred after getting the vaccine), GAIT DISTURBANCE (Can not walk because of fast heart beating.), HEADACHE (Headaches) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2021, Blood pressure measurement: 180/110 (High) 180/110 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient after some minutes of receiving the vaccine began to experience a rise in the blood pressure. The blood pressure value noted was 180/110 mm Hg. The patient also experienced nausea, pains at chest, arm, and redness for 12 times went to emergency room. The patient felt like they had a weight on the chest and was not able to walk because of fast heart beating. The patient also reports of having headaches, and was coughing a lot, including runny nose.   The patient was treated with blood pressure medication because of the rising blood pressure occurred post receiving the vaccine.   Reportedly, a nurse thinks that the patient was allergic to dye contrast.  No Concomitant product use was reported.
Discharge summary: "Patient is a 74-year-old female with a past medical history of Graves disease, hypertension being admitted with COVID pneumonia. Pt's husband was sick a couple of weeks ago, and last week she started feeing ill. SHe has had progressive SOB and coughing, associated with significant fatigue and exhaustion. SHe has body aches and everything smells weird. She has a hx of smoking. Patient denies chest pain, abdominal pain, nausea vomiting diarrhea constipation, swelling, rash, fevers.  No focal weakness.   She is vaccinated against COVID x2. "
Pt recvd vax & 5 min later fainted on father's lap; VS P64, Resp20, BP 110/70; pt was unconscious for 4-5 seconds; awoke & oriented x 3 & denied c/o h/a, dizziness or blurred vision; client was observed for 30 min; no further sxs observed;
I thought I was having allergies and for about three days I just thought it was allergies. I had been at an event and was told that people were testing positive so I took a home test on both the 25th and 26th which were both positive for COVID-19. I went to a pharmacy for a COVID-19 PCR test and that was positive as well. I was having a bad runny nose but was really congested in my sinus'. I had a really bad sore throat and cough as well. I have this tightness in my chest and its like I can't get a breath in and there is this resistance or my lungs are pushing back on me, that still happens after recovering. I also had issues my legs, where it is almost restless leg syndrome at night where there is this tension and dull ache in my legs. This also happens during the day and its hard to stand up and it makes it hard to sleep as well but that has subsided.
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) in a 28-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included Alcohol use (Prior use to pregnancy). Concurrent medical conditions included Type 1 diabetes mellitus since November 2014, Latex allergy and Penicillin allergy. Concomitant products included INSULIN LISPRO (HUMALOG) for Type 1 diabetes mellitus, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for Vitamin supplementation. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Sep-2020 and the estimated date of delivery was 23-Jun-2021. On 07-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. On 07-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (vaccine exposure during pregnancy) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Dec-2020, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported. This is a case of product exposure during pregnancy with no associated AEs for this 28-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.  This is a case of product exposure during pregnancy with no associated AEs for this 28-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jan-2021: Internal review on 23-Jul-3021 resulted in updates to pregnancy details.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 28-year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
PATIENT WAS VACCINATED WITH SECOND DOSE OF MODERNA COVID VACCINE AND THAT NIGHT EXPERIENCED ITCHING OF THE EYES, FEVER, AND BODY ACHES. NEXT MORNING PATIENT WOKE UP WITH RASH AROUND EYES. PATIENT SEEKING CARE AT CVS MINUTE CLINIC.
Caller reports no additional AE or PQC.; a patient was administered a dose of PROQUAD on 4/15/2021 that had a labeled expiry of 4/6/2021; This spontaneous report has been received from a nurse, referring about a 5-year-old patient of unknown gender. Information about the patient's pertinent medical history, concurrent conditions, concomitant medications and previous drug reactions and allergies was not provided.  On 15-APR-2021 the patient was vaccinated with a dose of  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (therapy type: rHA), at a dose of 0.5 milliliter (mL) and lot number S031705; that had a labeled expiry of 06-APR-2021 (expired product administered), for prophylaxis (frequency, route of administration or anatomical location were not provided).  The caller reported there were no temperature excursions related to the dose and no additional adverse events were reported.
Headache, nausea, tiredness, and fever. Patient slept over 15 hours and is still continuously sleeping throughout the day
sore injection site arm; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE PAIN (sore injection site arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In August 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore injection site arm). At the time of the report, VACCINATION SITE PAIN (sore injection site arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. The treatment information were unknown.
Severe pain at location of injection that persisted for more than two months. Only improved after taking antihistamine for several days.
had left arm numbness and tingling since vaccine referred to neurology and they are recommending EMD results tbd
I woke up on 11/8/2021 with a slight burning sensation when I peed. I was able to see a very tiny cut on the inner right labia. On 11/9/2021 a small ulcer formed in a different and a second cut formed an ulcer as well.  This was a covid booster and I had this happen with my original vaccine too. Last time this happened I was perscribed 3% topical lidocaine cream which helps with the pain and that is what I have been using.
Soon after receiving the 2nd moderna covid shot she began to have crippling migraines that took her off work for a year. She is back at work now, but the migraines are just as bad. Additionally, she put on 40 pounds rapidly.
I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 01/21/2023.  I felt like I had mild cold symptoms, but it got worse each day. When I tested positive for COVID-19 on 07/02/2022 I was sick for six to eight weeks. I had sore throat, I had nausea and vomiting and difficulty breathing. I did not get a prescription for Paxlovid.  I had developed both an ear and throat infection in addition to COVID-19. I took over the counter medication to help with my symptoms. My first case of COVID-19 was on 04/2022. I was given the prescription for Paxlovid. I tolerated the medication without any complications. As of today, I continue to have acid reflux that began when I had COVID-19 in 01/2023.
Pediatric Pfizer 5-11y Bivalent booster. Incorrect dose was administered - vial was diluted with  0.3 mL instead of proper 1.3 mL. Dose was double normal dose as a result - 20 mcg rather than the normal 10 mcg. Pt experienced drowsiness, headache, nausea and vomiting within 3 hours after receiving dose that was double normal dose.
This spontaneous report as received from a Licensed Practical Nurse refers to an 81 years old female patient with codeine allergy. On an unspecified date the patient was vaccinated SC with 1 dose, 0.65 ml ZOSTAVAX (lot number not reported). No other co-suspects were reported. No concomitant medications were reported. On 02-AUG-2011 the patient developed shingles that characterized by a burning rash in her left breast and left arm area. The patient had contacted physician and was treated with VALTREX and recovered "a week later", on approximately 09-AUG-2011. This is one of several reports received from the same source. Additional information is not expected.
COVID-19 vaccination induced myocarditis He received 2nd COVID vaccine (Pfizer) on 9-7-21.  Unfortunately, a few days later he was admitted with severe chest pain and shortness of breath.  He had profoundly elevated cardiac markers.  CTPE protocol negative, cardiac cath clear, echo unremarkable.  Ultimately he was felt to have vaccine-induced myocarditis.
Moderna Bivalent Doses administered after 30 day use by date.; Moderna Bivalent Doses administered after 30 day use by date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.), POOR QUALITY PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 10-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.), POOR QUALITY PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.), POOR QUALITY PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.) and POOR QUALITY PRODUCT ADMINISTERED (Moderna Bivalent Doses administered after 30 day use by date.).    Treatment medication information was not provided by the reporter. No medical history was reported by the reporter.  Patient not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. It was reported that  Moderna Bivalent Doses administered after 30-day used by date. 1 dose on 10-Dec-2022, 2 doses on 11-Dec-2022 and 1 Dose on 12-Dec-2022.